Request Demo
Last update 15 May 2025
Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)
Last update 15 May 2025
Overview
Basic Info
Drug Type Interferons, Biosimilar |
Synonyms Recombinant Human Interferon α2b, 干扰素α2b生物类似药（长春生物制品）, Changshengfukang + [1] |
Target |
Action agonists, stimulants, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2000), |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 26333714
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)CTR20222193
原液工艺变更后人干扰素α2b注射液和注射用人干扰素α2b两制剂在健康受试者中的PK/PD比较研究
[Translation] Comparative PK/PD study of human interferon α2b injection and human interferon α2b for injection after the original solution process was changed in healthy subjects
CTR20191337
重组人干扰素 α2b 注射液和注射用重组人干扰素 α2b 在健康受试者中的 PK/PD 比较研究
[Translation] Comparative PK/PD study of recombinant human interferon α2b injection and recombinant human interferon α2b for injection in healthy subjects
100 Clinical Results associated with Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)
Login to view more data
100 Translational Medicine associated with Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)
Login to view more data
100 Patents (Medical) associated with Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)
Login to view more data
100 Deals associated with Interferon alfa-2b biosimilar(Changchun Institute of Biological Products)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Condylomata Acuminata | China | 01 Jan 2000 | |
| Hairy Cell Leukemia | China | 01 Jan 2000 | |
| Hepatitis | China | 01 Jan 2000 | |
| Hepatitis, Chronic | China | 01 Jan 2000 | |
| Philadelphia chromosome positive chronic myelogenous leukemia | China | 01 Jan 2000 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute viral hepatitis | Phase 1 | China | 10 Jul 2019 | |
| Chronic viral hepatitis | Phase 1 | China | 10 Jul 2019 | |
| Herpes Zoster | Phase 1 | China | 10 Jul 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free